Analysis of the Clinical Efficacy of Modified New Medical Bone-setting Therapy Combined with PVP in the Treatment of Osteoporotic Thoraco-lumbar Fractures
Objective To investigate the application advantages of modified new medicine bone-setting therapy com-bined with percutaneous vertebroplasty(PVP)and percutaneous kyphoplasty(PKP)in patients with osteoporotic verte-bral compression fracture(OVCF).Methods The clinical data of 88 patients with OVCF admitted to Heze Hospital of Traditional Chinese Medicine from September 2019 to September 2022 were retrospectively selected.According to the different treatment methods received by the patients,the observation group(n=62)was treated with modified new medical bone-setting therapy combined with PVP,and the control group(n=26)was treated with PKP alone.The ver-tebral height,thoracolumbar Cobb angle,bone cement injection volume,operation time,hospitalization days and com-plication rate were compared between the two groups.Results After treatment,the operation time of the observation group(39.50±3.03)min was shorter than that of the control group(42.32±5.01)min,and the difference was statisti-cally significant(t=2.098,P=0.039).There was no significant difference in vertebral height,thoracolumbar Cobb angle,bone cement injection volume,hospitalization days and complication rate between the two groups(all P>0.05).Conclusion The combination of improved new medicine bone-setting therapy and PVP can achieve similar clinical ef-ficacy and prognostic safety as PKP therapy,but the orthopedic time of the combined therapy is shorter.
Percutaneous vertebroplastyPercutaneous kyphoplastyOsteoporosisFractureThoracolumbar spineVertebral body height